Skip to main content

New strategy and clear focus

  • Fresenius has hit RESET and is now moving towards #FutureFresenius with a simplified structure, sharper focus and acceleration of performance
  • Intention to deconsolidate Fresenius Medical Care by changing the legal form of FMC to a German Stock Corporation (“Aktiengesellschaft”) in simplified governance
  • Focus on Operating Companies Fresenius Kabi and Fresenius Helios
  • Active portfolio management for assets where Fresenius lacks best ownership
  • New, more rigorous Fresenius Financial Framework with ambitious segment margin bands
  • ~€1bn annual structural productivity improvement by 2025
Image Desc.

November 02, 2023
Bad Homburg, Germany

Conference Call Q3 2023, Fresenius


Next event

“We are keeping a quick and consistent pace in implementing our #FutureFresenius program. And the effects are becoming tangible. Our Operating Companies, Fresenius Helios and Fresenius Kabi, have top market positions, and are bringing innovations to patients every day. Both delivered solid second quarter results, including stronger than expected revenue growth. Both are within their respective margin bands, which we established earlier this year as part of our new financial framework...

Michael Sen, Chairman of the Management Board

Non-financial and Sustainability Reporting

We are committed to being a socially and environmentally responsible corporate player in the global healthcare market. We have the ambition to shape future healthcare and build a sound base for sustainable growth.



Social Media

By clicking “I consent” you consent to the activation of the activity feed on this website and the following processing of your personal data related to it according to Section 2 of the Privacy Statement